Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Pedro Barata, MD

Pedro Barata, MD

  • Specialty: Hematology and Oncology
    View Expertise
  • Primary Location: 3909 Orange Pl (7 mi.)
    Other Locations
  • Languages Spoken: English, Portuguese, Spanish

Office Locations

UH Seidman Minoff Health Center (7 mi.)

3909 Orange Pl
Ste 1100
Beachwood, OH 44122
216-896-1750

UH Seidman Cancer Center (0 mi.)

11100 Euclid Ave
1st Floor
Cleveland, OH 44106
216-844-3951

UH Seidman Minoff Health Center (7 mi.)

3909 Orange Pl
Ste 4600
Beachwood, OH 44122
216-844-3951

Biography: Pedro Barata, MD

Expertise

  • Clinical Research
  • Experimental Therapeutics
  • GU Medical Oncology
  • Kidney Cancer
  • Prostate Cancer

Titles

  • Director, Clinical Genitourinary Medical Oncology Research Program, UH Seidman Cancer Center
  • Miggo Family Chair in Cancer Research, University Hospitals

Certifications & Memberships

  • Medical Oncology - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine

Education

Fellowship | Experimental Therapeutics
Experimental Therapeutics - Cleveland Clinic - Taussig Cancer Center (2016 - 2018)

Fellowship | Medical Oncology
Medical Oncology - Alameda Santo Antonio Dos Capuchos (2013 - 2016)

Other Education
University Of Lisbon, Faculty Of Medicine (2015)

Medical Education
Nova Medical School (2009)

About

Pedro C. Barata, MD, MSc is a board-certified, fellowship-trained medical oncologist at University Hospitals Seidman Cancer Center and an Associate Professor of Medicine at Case Western Reserve University School of Medicine. His special clinical interests include kidney, prostate and bladder cancers.

Dr. Barata is also a renowned clinical trialist and researcher and serves as Director of the Clinical Genitourinary Medical Oncology Research Program at University Hospitals Seidman Cancer Center. His research interests include experimental therapeutics, the molecular profiling of tumors and genomic-based therapies for genitourinary tumors.

After completing his fellowship in medical oncology, Dr. Barata came to the United States in 2016 where he completed a clinical fellowship in experimental therapeutics in genitourinary tumors at the Cleveland Clinic Taussig Cancer Center in Cleveland, Ohio. During that time, he also rotated at the phase I / Experimental Therapeutics Department at MD Anderson Cancer Center, Houston, Texas.

Dr. Barata is an active member in numerous professional committees and societies, including the American Urological Association, the American Society of Clinical Oncology, the American Association for Cancer Research and the Society for Immunotherapy of Cancer.

The recipient of numerous research and education grants, Dr. Barata is a prolific author and co-author, with dozens of published studies and citations to his credit. Most recently, he was named as the Associate Editor of the ASCO Educational Book, an annual publication that serves to educate all members of the oncology care team on practice-changing oncology research so patients can receive the highest-quality, equitable care. Topics for the peer-reviewed articles are selected by ASCO’s Annual Meeting Education Committee and authored by the Annual Meeting Education Program faculty and international experts in oncology. Dr. Barata also serves as the Prostate Cancer Section Editor for the Oncologist journal and is a member of the editorial team of the Translational Oncology journal.

Research & Publications

Research Links

PubMed
View Research

Featured Videos

Watch to find out more about this University Hospitals provider.

Patient Experience Reviews

4.8 out of 5
- based on 103 Ratings
(5)
11/1/2024

We are very thankful for Dr. Barata and his knowledge concerning this illness. We would like to thank him for all he has done and hopefully will continue to do for this patient

(5)
11/1/2024

*** He was a good doctor ***

(5)
10/1/2024

Great experience as usual.

(5)
10/1/2024

Very pleased.

(5)
8/1/2024

I am very satisfied with my care.

(5)
8/1/2024

Excellent

(5)
7/1/2024

My care during visit was very good. The doctor gave me important information about my illness.

(5)
6/1/2024

Dr. Barata is fabulous! UH is lucky to have him on staff!

(5)
5/1/2024

I came to see Dr. Barata as a second opinion to see if there was any options for my medical condition. I have advanced ***. It's a difficult case. Dr. Barata was very encouraging. ***

(5)
5/1/2024

I cannot express how grateful the entire UH TEAM has supported me and provided excellent care. Dr Barata has worked hard for me to get a true diagnosis and understanding of my condition and a treatment plan in place.

(5)
4/1/2024

Good experience

(5)
4/1/2024

The Dr. Was excellent and took a lot of fear away from my cancer and gave me hope. He had a wonderful sense of humor which relaxed me as I was scared of my condition.

(5)
3/1/2024

Dr Barata is a very knowledgeable and caring Physician. He encouraged us as a family! He truly made a difference in how to best approach a situation with narrow pathways using the best plan.

(5)
3/1/2024

Good

(5)
3/1/2024

I was impressed with the quality of service!

(5)
2/1/2024

Dr. Barata and his team are very knowledgeable, professional, and caring.

(5)
1/1/2024

*** everything was OK

(5)
1/1/2024

The physicians assistant and nurse are both excellent and very helpful. They get back to you ASAP.

(5)
1/1/2024

Very good experience, excelent specialist doctor.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Pedro Barata did not disclose any Outside Relationships with Industry.